73. Custodiol versus blood cardioplegia in pediatric cardiac surgery  by Qulaissi, Ebtehal et al.
total operative times. Postoperative data included the fre-
quency of hyperglycemic patients, occurrence of PO mor-
bidities and mortality. All hyperglycemic patients
received insulin infusion adjusted to achieve RBG level
of 126–179 mg/dl.
Results: All patients had significantly higher postopera-
tive RBG levels compared to preoperative levels. Forty-
three patients were hyperglycemic, while 57 patients were
considered normoglycemic. Throughout ICU and hospital
stay, 31 patients developed morbidities and 4 patients
died with significantly higher frequency of additional
morbidities and mortalities in hyperglycemic versus
normoglycemic patients. There was positive significant
correlation between the frequency of PO morbidities and
mortality and extent of PO hyperglycemia, aortic clamp-
ing, CPB and total operative times. ROC curve and regres-
sion analyses showed that the extent of PO hyperglycemia,
aortic clamping, CPB and total operative times are the
significant predictors for morbidities and mortalities.
Conclusion: PO hyperglycemia showed deleterious
effects on outcome of CABG patients manifested as
increased frequency of morbidities and mortalities dur-
ing ICU and hospital stay and the extent of hyper-
glycemia could be considered as independent predictor
of worsened outcome. The applied management policy
allowed reduction of blood glucose levels without induc-
ing hypoglycemia with subsequent improved outcome.
http://dx.doi:10.1016/j.jsha.2015.05.253
73. Custodiol versus blood cardioplegia in pedi-
atric cardiac surgery
Ebtehal Qulaissi, Osman Al-Radi, Rajab Debes
Introduction: Cardioplegia is a solution used to arrest and
protect the heart during open cardiac repair with the use
of cardiopulmonary-bypass. Two types of cardioplegia
were evaluated. Blood cardioplegia and HTK crystalloid
cardioplegia known as Custodiol.
Objectives: To evaluate the efficacy of myocardial protec-
tion with antegrade intermittent oxygenated blood car-
dioplegia in comparison to a single dose of Custodiol in
pediatric cardiac surgery.
Methods: A retrospective cohort study was performed
between November 1st, 2013 and June 30th, 2014. Fifty-
two patients underwent congenital heart procedure at
King Abdul-Aziz University Hospital with the use of
cardiopulmonary-bypass and cardioplegia. Forty-two
received blood cardioplegia and ten received Custodiol.
Data were collected from operative reports, electronic and
paper charts. Statistical analysis was done using Pearson-
test for continuous data and Kruskal–Wallis-test for cate-
gorical data. P-Value of 0.05 was considered significant.
Results: Patients in the Custodiol group experienced
longer duration of cardiopulmonary-bypass time (med-
ian value of 84 versus 77.5 min), aortic clamping time
(63 versus 50.5 min) and total operation time (175 versus
144 min), compared to the Blood group. The duration of
mechanical ventilation was longer in the Custodial
group, 72 versus 48 h in the Blood group (p = 0.016). The
incidence of post-operative arrhythmia requiring treat-
ment was also higher in Custodiol group, 50% versus
12% in the Blood group (p = 0.02). Low output syndrome,
acute kidney injury and death were not statistically sig-
nificantly different between two groups.
Conclusions: Custodiol may have inferior myocardial
protection compared to blood cardioplegia in children
undergoing cardiac surgery. A randomized comparison
is warranted.
http://dx.doi:10.1016/j.jsha.2015.05.254
74. Bone density in heart transplanted patients in
Kingdom of Saudi Arabia
Nedim Selimovic, Asmi Nisar, Jehad Alburaiki,
Feras Khaliel
Background: Osteopenia and osteoporosis are prevalent
in heart transplant candidates. Early, rapid bone loss is
a well documented complication of steroid administra-
tion after heart transplantation. Purpose of our study
was to determine incidence of osteopenia and osteoporo-
sis in heart transplant candidates and heart transplanted
patients and association with demographics characteris-
tics, vitamin D deficiency, renal and thyroid function
and long-term use of corticosteroids and immunosup-
pressive drugs.
Methods: This is a non-randomized, retrospective, obser-
vational study. Medical files of all consecutive heart
transplanted patients since the beginning of 2009 until
August 2013 were reviewed.
Results: Pre-transplant bone mineral density data (BMD)
were available in 63 heart transplant recipients; 54 and
32, respectively, also had 1- and 2-years post-transplant
BMD data. Pre-transplant lumbar spine (LS) osteopenia
or osteoporosis was 35% and 8% compared with 30%
and 3% in femoral neck (FN). We found significant
decrease in pre-transplant BMD compared with BMD
data 1 year after heart transplantation in LS (1.034 ± 0.17
vs.0.994 ± 0.13; p < 0.001) and FN (0.951 ± 0.15 vs.
0.879 ± 0.139; p < 0.001), respectively. There were no sig-
nificant changes in BMD after 2 years compared with
data with 1 year BMD in LS (p = 0.98) and FN (p = 0.11),
respectively. BMD in LS and FN were significantly lower
in female (0.92 ± 0.157 vs. 1.06 ± 0.163, p = 0.009 and
0.869 ± 0.11 vs. 0.985 ± 0.147, p = 0.017) despite younger
age (26 ± 10 vs. 39 ± 13 year, p < 0.001). Vitamin D defi-
ciency is highly representative in the Saudi population
(69% of recipients have severe deficiency, level <
25 nmol/L). One year after transplantation 94% of
patients are on Vitamin D3 supplement and 91% on
Calcium supplement. Despite reduction of severe VITD
deficiency to only 8.6% we have significant progress of
osteopenia and osteoporosis 1 year after HTx. We have
registered 100% use of corticosteroids 1 year after HTx.
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